Arix Bioscience Plc

Arix Bioscience (ARIX)

Company name:Arix Bioscience Plc
EPIC:ARIXTrading Currency:GBX
Market Sector:SQS3ISIN:GB00BD045071
Market Segment:SSQ3Share Type:DE
WWW Address: 0.001P
 Price Price Change [%] Bid Offer Open High Low Volume
 177.00 0.0 [0.00] 175.00 179.00 177.00 177.00 177.00 10,908
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 235.94 133.30 0.09 96.60 - 1.83 - 229.00 - 76.00

Arix Bioscience Key Figures

(at previous day's close)
Market Cap.235.94m
Shares In Issue133.30m
Prev. Close177.00
PE Ratio1.83 
Dividend Yield-%
EPS - basic96.60p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-5.05p
Return On Equity (ROE)38.41%
Operating Margin26,478.20%
PEG Factor0.01 
EPS Growth Rate279.55%
Dividends PS Growth Rate-%
Net Debt-109.58m
Gross Gearing0.76%
Quick Assets175.74m
Net Working Capital173.50m
Intangibles / Fixed Assets0.26%
Turnover PS0.36p
Pre-Tax Profit PS94.75p
Retained Profit PS94.58p
Cash PS84.09p
Net Cash PS82.41p
Net Tangible Asset Value PS *245.92p
Net Asset Value PS246.22p
Spread4.00 (2.23%) 

Arix Bioscience Balance Sheet


Share Price Performance

Sample Period HighLow
1 week178.00176.00
4 weeks180.00174.00
12 weeks186.50174.00
1 year229.0076.00

Share Price Chart (5 years)

Arix Bioscience Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week176.500.500.28176.000.06177.12
4 weeks178.00-1.00-0.56174.000.07177.02
12 weeks185.00-8.00-4.32174.000.11179.29
26 weeks173.004.002.31170.500.22188.92
1 year76.50100.50131.3776.000.17177.78
3 years173.503.502.0258.500.11150.81
5 years210.00-33.00-15.7158.500.09158.20

Arix Bioscience Key Management Ratios

Arix Bioscience Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio1.83 
Tobin's Q Ratio 0.87 
Tobin's Q Ratio (excl. intangibles)0.88 
Dividend Yield-%
Market-to-Book Ratio0.72 
Price-to-Pre-Tax Profit PS1.87 
Price-to-Retained Profit PS1.87 
Price-to-Cash Flow PS-35.05 
Price-to-Sales PS494.63 
Price-to-Net Tangible Asset Value PS0.72 
Price-to-Cash PS2.10 
Net Working Capital PS130.16 
Price Pct to Working Capital PS1.36%
Earnings Yield54.58%
Average PE3.73 
Years in average2 
PE to PE average49.16%

Arix Bioscience Financial Ratios

(Leverage Ratios)
Debt Ratio0.08%
Debt-to-Equity Ratio0.00 
Debt-to-Equity Ratio (excl. Intgbl)0.00 
Debt-to-Equity Market Value0.00 
Net Gearing-33.14%
Net Gearing (excl. Intangibles)-33.18%
Gross Gearing0.76%
Gross Gearing (excl. Intangibles)0.76%
Gearing Under 1 Year0.68%
Gearing Under 1 Year (excl. Intgbl)0.68%
(Liquidity Ratios)
Net Working Capital to Total Assets52.46%
Current Ratio78.63 
Quick Ratio (Acid Test)78.63 
Liquidity Ratio50.15 
Cash & Equiv/Current Assets63.78%
(Solvency Ratios)
Enterprise Value124.12m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.01 
Total Debt/Sales5.25 
Total Debt/Pre-Tax Profit0.02 
Total Debt2.50m
Total Debt/Net Current Assets0.01%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth44.37%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta (60-Mnth)Beta (36-Mnth)

Arix Bioscience Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)38.45%
Return On Assets (ROA)46.70%
Net Profit Margin26,431.03%
Assets Turnover0.00 
Return On Equity (ROE)38.41%
Return On Investment (ROI)47.50%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio47.55%
Net Income Of Revenues26,431.03%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.00 
Fixed Assets Turnover0.00 
Current Assets Turnover0.00 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales565.96 
Debt Collection Period24,249.93Days

Arix Bioscience Dividends

Sorry No Data Available

Arix Bioscience Fundamentals

 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
pre tax profit-7.69-414.11%42.763,219.95%-75.57-126.30-m
attributable profit-8.61-463.76%38.152,872.52%-69.87-126.08-m
retained profit-8.61-463.76%38.152,872.52%-69.87-126.08-m
eps - basic (p)-0.11 32.10 -53.80 96.60 
eps - diluted (p)-0.11 29.70 -53.80 88.60 
dividends per share- - - - 

Arix Bioscience Balance Sheet

 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
fixed assets fixed assets0.520.35%0.310.11%0.160.08%0.050.01%m
intangibles intangibles2.061.37%1.770.63%1.030.49%0.400.12%m
fixed investments fixed investments71.3347.52%183.9865.84%152.2972.79%154.5246.72%m
current assets - other current assets - other--%--%--%1.380.42%m
stocks stocks--%--%--%--%m
debtors debtors1.270.84%2.170.78%1.110.53%62.2818.83%m
cash & securities cash & securities74.9449.92%91.2232.64%54.6426.12%112.0933.89%m
creditors - short creditors - short3.672.44%9.283.32%6.843.27%2.240.68%m
creditors - long creditors - long--%--%0.270.13%0.270.08%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves146.4497.56%270.1796.68%202.1196.60%328.2199.24%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Arix Bioscience Cash Flow Statement

31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
Operating CF-8.78-11.06-8.47-6.73m
Pre-Financing CF-59.03-126.5025.6659.59m
Retained CF46.05-44.2524.6859.59m

Arix Bioscience Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
Arix Biosc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210805 10:31:06